ECT Effective for Treatment-Resistant Depression

Share this content:
ECT Effective for Treatment-Resistant Depression
ECT Effective for Treatment-Resistant Depression

MONDAY, May 14, 2018 (HealthDay News) -- Electroconvulsive therapy (ECT) may be effective and cost-effective for U.S. patients with treatment-resistant depression, according to research published online May 10 in JAMA Psychiatry.

Eric L. Ross, from the University of Michigan Medical School in Ann Arbor, and colleagues examined the cost-effectiveness of ECT versus pharmacotherapy/psychotherapy for treatment-resistant major depression. Data were included from multiple meta-analyses, randomized trials, and observational studies.

The researchers simulated a population with a mean age of 40.7 years based on the Sequenced Treatment Alternatives to Relieve Depression trial. ECT was projected to reduce time with uncontrolled depression from 50 to 33 to 37 percent of life-years over four years; greater improvements were seen when ECT was offered earlier. There was an increase in mean health care costs by $7,300 to $12,000; the incremental costs were greater when ECT was offered earlier. Third-line ECT was cost-effective in the base case, with an incremental cost-effectiveness ratio of $54,000 per quality-adjusted life-year. In a range of univariate, scenario, and probabilistic sensitivity analyses, third-line ECT remained cost effective. The likelihood that at least one ECT strategy is cost-effective was estimated at 74 to 78 percent incorporating all input data uncertainty; there was a 56 to 58 percent likelihood that third-line ECT was the optimal strategy.

"These data suggest that, from a health-economic standpoint, ECT should be considered after failure of two or more lines of pharmacotherapy/psychotherapy," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Warns About 'Miracle' Young Blood Infusion Treatments

FDA Warns About 'Miracle' Young Blood Infusion Treatments

Expensive 'fountain of youth' therapies are unproven, potentially harmful

CDC: Salmonella Cases Tied to Raw Turkey Products Now at 279

CDC: <i>Salmonella</i> Cases Tied to Raw Turkey Products ...

Cases reported in 41 states and the District of Columbia; 107 people have been hospitalized

Chronic Wasting Disease Found in Deer in 24 States

Chronic Wasting Disease Found in Deer in 24 ...

No evidence disease can spread to humans, but hunters should be careful around potentially infected animals

is free, fast, and customized just for you!




Already a member?

Sign In Now »